Synapse email

One way Synapse protects your privacy is by not exposing the email address you used to register with the system. However now you may contact other users via email by using the address, <username>@synapse.org, where <username> is the name shown on an individual’s dashboard (and elsewhere in the system). You may also broadcast messages to a Synapse Team on which you are a member by emailing <team>@synapse.org, where <team> is the name of the team (leaving out spaces and other email-address-illegal characters). For security (and to block spam), you must send all Synapse emails from an address which you registered with Synapse. You can turn off email notifications at any time from your dashboard settings page. We hope that this new feature will allow you to contact other users directly with questions about their work, strike up new collaborations, and communicate with DREAM Challenge participants or organizers. As always, we welcome your feedback.

-The Synapse Team

Advertisements

About Brian Bot
I am a Principal Scientist working in Computational Oncology at Sage Bionetworks in Seattle, Washington and Community Manager for our technology platforms. Previously, I worked in the Department of Biomedical Statistics and Informatics at the Mayo Clinic for 7 years. This work included 7 years of dealing with cancer clinical trial data as part of the Mayo Clinic Cancer Center (MCCC). I have extensive experience in working with clinical and genomic data and have a passion for exploring innovative ways to make science more open and transparent. My current work involves both doing innovative research in computational oncology as well as serving as a bridge between biomedical researchers and technology development. At its heart, this work is driven to re-envision how scientists can ensure reproducibility of their research results and communicate complex science to one another and to the public at large. I have been an invited speaker at a number of national and international events to share my experiences living at the intersection of biomedical research and technology.

Comments are closed.

%d bloggers like this: